Movement Disorders (revue) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Mécanisme action »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mécanisme < Mécanisme action < Médecin  Facettes :

List of bibliographic references indexed by Mécanisme action

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
002790 (2008) Constance Hammond [France] ; Rachida Ammari [France] ; Bernard Bioulac [France] ; Liliana Garcia [France]Latest view on the mechanism of action of deep brain stimulation
003F10 (2003) Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
004085 (2003) Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada]Fipamezole (JP‐1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease
004136 (2003) Ruediger Hilker [Allemagne] ; Juergen Voges [Allemagne] ; Mehran Ghaemi [Allemagne] ; Ralf Lehrke [Allemagne] ; Jobst Rudolf [Allemagne] ; Athanasios Koulousakis [Allemagne] ; Karl Herholz [Allemagne] ; Klaus Wienhard [Allemagne] ; Volker Sturm [Allemagne] ; Wolf-Dieter Heiss [Allemagne]Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans
004160 (2003) Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa‐induced motor complications
004233 (2002) Ergun Y. Uc [États-Unis] ; Gerald A. Dienel [États-Unis] ; Nancy F. Cruz [États-Unis] ; Sami I. Harik [États-Unis]β‐Adrenergics enhance brain extraction of levodopa
004389 (2002) Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada]Mechanisms of deep brain stimulation
004390 (2002) Alim-Louis Benabid [France] ; Abdelhamid Benazzous [France] ; Pierre Pollak [France]Mechanisms of deep brain stimulation
004391 (2002) Jerrold L. Vitek [États-Unis]Mechanisms of deep brain stimulation: Excitation or inhibition
004693 (2001) Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Féger [France]Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain
004723 (2001) Jon H. Falkenberg [États-Unis] ; Paul A. Iaizzo [États-Unis] ; Linda K. Mcloon [États-Unis]Physiological assessment of muscle strength in vitro after direct injection of doxorubicin into rabbit sternocleidomastoid muscle
004745 (2001) Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]Neural mechanisms underlying peak‐dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan
004760 (2001) Fabrizio Stocchi ; Laura Vacca ; Alfredo Berardelli ; Francesca De Pandis ; Stefano RuggieriLong‐duration effect and the postsynaptic compartment: Study using a dopamine agonist with a short half‐life
004826 (2001) Y. R. Wu [Taïwan] ; R. Levy [Canada] ; P. Ashby [Canada] ; R. R. Tasker [Canada] ; J. O. Dostrovsky [Canada]Does stimulation of the GPi control dyskinesia by activating inhibitory axons?
004845 (2001) Krishna P. Datla [Royaume-Uni] ; Stavia B. Blunt [Royaume-Uni] ; David T. Dexter [Royaume-Uni]Chronic L‐DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6‐OHDA or FeCl3 nigrostriatal lesions
004A00 (2000) Pieter Joost Van Wattum [États-Unis] ; Phillip B. Chappell [États-Unis] ; Daniel Zelterman [États-Unis] ; Lawrence D. Scahill [États-Unis] ; James F. Leckman [États-Unis]Patterns of response to acute naloxone infusion in Tourette's syndrome
004A78 (2000) Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Endogenous dopaminergic tone and dopamine agonist action
004B70 (2000) Abstracts from International Conference 1999: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Orlando, FL, USA, November 16-18, 1999
004B73 (2000) Hasmet A. Hanagasi [Turquie] ; Gülüstü Kaptanoglu [Turquie] ; Hüseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa
004C29 (1999) Sybille Spieker [Allemagne] ; Peter-Andreas Löschmann [Allemagne] ; Thomas Klockgether [Allemagne]The NMDA antagonist budipine can alleviate levodopa‐induced motor fluctuations
004D13 (1999) Dieter Kunz [Allemagne] ; Frederik Bes [Allemagne]Melatonin as a therapy in rem sleep behavior disorder patients: An open‐labeled pilot study on the possible influence of melatonin on rem‐sleep regulation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Mécanisme action" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Mécanisme action" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Mécanisme action
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024